Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...
Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...
Annual General Meeting of the Irish Thoracic Society - IJMS | Irish ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
1<br />
SESSION ONE<br />
1<br />
ANNUAL MEETING OF THE IRISH THORACIC SOCIETY • 11 - 12 November 2005 • WESTWOOD HOUSE HOTEL, GALWAY ANNUAL MEETING OF THE IRISH THORACIC SOCIETY • 11 - 12 November 2005 • WESTWOOD HOUSE HOTEL, GALWAY<br />
SESSION ONE<br />
1.4<br />
1.5<br />
Influence <strong>of</strong> CFTR genotype on pulmonary disease in adult<br />
Cystic Fibrosis patients from Belfast and Dublin referral centres<br />
Background<br />
In referring to differences in survival between Cystic<br />
Fibrosis (CF) patients in <strong>the</strong> Republic and Nor<strong>the</strong>rn<br />
Ireland, <strong>the</strong> recent Pollock Report 1 also cautions<br />
on <strong>the</strong> interpretation <strong>of</strong> available data, citing<br />
variation in diagnosis and coding as factors that can<br />
complicate comparisons. Ano<strong>the</strong>r factor that can<br />
greatly influence survival in CF is CFTR genotype.<br />
The aim <strong>of</strong> this study was to evaluate differences in<br />
CFTR genotype between CF patients attending adult<br />
referral centres in Dublin and Belfast and to assess<br />
<strong>the</strong> influence <strong>of</strong> <strong>the</strong>se differences on pulmonary<br />
function, a major indicator <strong>of</strong> pulmonary prognosis<br />
and survival in CF.<br />
Methods<br />
CFTR genotypes on 205 patients attending <strong>the</strong><br />
Dublin centre and 115 patients attending <strong>the</strong> Belfast<br />
centre were collected. Pulmonary function was<br />
assessed on all patients when clinically stable with<br />
no evidence <strong>of</strong> acute infection.<br />
Results<br />
Just over half (50.4%) <strong>of</strong> <strong>the</strong> Belfast group had CFTR<br />
Introduction<br />
The management <strong>of</strong> acute pulmonary exacerbations<br />
in Cystic Fibrosis has changed in recent years with<br />
<strong>the</strong> increasing usage <strong>of</strong> home intravenous <strong>the</strong>rapy.<br />
Method<br />
A retrospective examination <strong>of</strong> hospital admission<br />
<strong>of</strong> patients with acute pulmonary exacerbations<br />
<strong>of</strong> Cystic Fibrosis in 2004 was carried out. Total<br />
admission figures were derived from <strong>the</strong> HIPE<br />
system. A review <strong>of</strong> all home IV prescriptions during<br />
this time was performed. This was accompanied<br />
by review <strong>of</strong> FEV1 values and sputum culture and<br />
sensitivity corresponding with time <strong>of</strong> exacerbation.<br />
Results<br />
In total <strong>the</strong>re were over 300 episodes <strong>of</strong> acute<br />
exacerbations in 2004. There were 298 admissions<br />
to SVUH with exacerbations in 2004. In this year<br />
131 courses <strong>of</strong> home IV’s were prescribed to 77<br />
patients. Of <strong>the</strong>se 104 were initiated and completed<br />
genotypes that are associated with mild disease<br />
compared only 25% <strong>of</strong> Dublin patients (p